Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $70.54 --0%
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $0.76, $0.15 better than the analyst estimate of $0.61. Revenue for the quarter came in at $415.6 million versus the consensus estimate of $370.72 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cisco expands AI infrastructure with Supermicro partnership
- Puma Exploration Completes 2,800 Line-Kilometres of Drone Magnetic Surveys
- EPAM Systems joins Wiz Partner Alliance for cloud security
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
